Skip to main content

Red wine may protect against breast cancer for some women at increased risk


As we have discussed here before, the question of alcohol consumption and breast cancer is a volatile one, but a new study helps to shed some light on the subject. It becomes especially difficult for a subset of women with a genetic trait that places them at increased risk. Two genes, called BRCA1 and BRCA2, are mutations of genes that normally code for tumor suppression. When one of these mutations is present, the chances of developing breast cancer are substantially increased, and it is now routine to test for them when there is a family history of breast cancer. And given the consensus that alcohol consumption further increases the odds of developing breast cancer, it might make sense that the BRCA gene and drinking would be an especially dangerous mix. But when it comes to red wine, the story takes a different turn.


This new study, from the University of Ottawa in Montreal, looked at a large population of women with breast cancer, and tested them for BRCA. Additionally, drinking habits were determined by questionnaire. Interestingly, women with BRCA1 who were primarily red wine drinkers had about half of the expected incidence, and alcohol had no correlation at all. For BRCA2 positive women, alcohol was independently associated with breast cancer but red wine had no relationship.

So for BRCA-positive women, the effect of red wine really depends on which type; BRCA2 women should probably seriously consider avoiding alcohol of any type (unless they choose to have prophylactic mastectomy with reconstruction) while BRCA1 women might seriously consider cultivating a taste for cabernet. It’s a confused message, since the original purpose of the study was to clarify the magnitude of alcohol as a risk factor for BRCA-positive women, but the unexpected benefit for wine drinkers adds a layer of complexity. It’s not the first crack in the consensus about wine and breast cancer though, since populations where wine is regularly consumed there is a much lower incidence of breast cancer. The difficulty is statistically teasing out the true wine drinkers from the mixed and erratic drinking patterns in most populations.

Comments

  1. On the questionnaire for alcohol consumption, only 10 BRCA1 women were measured. Do you really think that's a large enough sample to project the benefit of red wine for BRCA1 carriers?

    ReplyDelete

Post a Comment

Popular posts from this blog

Which came first: Beer or wine? (or something else?)

Actually neither beer nor wine was the first fermented beverage, and wine arguably has a closer connection to health, but recent evidence indicates that humans developed the ability to metabolize alcohol long before we were even human. The uniquely human ability to handle alcohol comes from the digestive enzyme alcohol dehydrogenase, or ADH4. A new science called paleogenetics identifies the emergence of the modern version of the ADH4 gene in our ape ancestors some 10 million years ago. Interestingly, this corresponds to the time when our arboreal forebears transitioned to a nomadic lifestyle on the ground. We went from swinging from tree limbs to walking upright, and the rest is history. Understanding the circumstances that led to perpetuation of the ADH4 mutation may contain clues to what made us human in the first place. How the ability to metabolize alcohol made us human Paleogenetecist Matthew Carrigan has an idea about how this happened . Arboreal species rely on fruit tha

Why I am not surprised that the NIH cancelled the alcohol-health study

Not long after enrolling the first patients in the much hyped prospective study on alcohol and health, the National Institutes of Health recently announced that they were pulling the plug. I am actually more surprised that they ever got it off the ground in the first place. As I wrote a year ago when the study was still in its planning stages, there were too many competing interests, criticisms of the study design, and concerns about funding to expect that whatever results came out would be universally accepted. Nevertheless, I am disappointed. The study, called Moderate Alcohol and Cardiovascular Health Trial (MACH) was intended to provide hard evidence about the health effects of moderate alcohol consumption by prospectively assigning subjects with heart disease to one drink per day or not drinking, which they were to follow for up to 10 years. Most existing data on the question is retrospective, or simply tracks a subject population according to their drinking preferences, w